is januvia a glp-1 drug New Guidelines for Type 2 Diabetes in 2025 Sitagliptin - Wikipedia
Description
Label also updated with clinical trials reports of dysesthesia (unpleasant or altered sense of touch)
Ready for a personal plan
doi: 10.2337/dc13-1283
Titrate up gradually based on response, and you may find your new effective dose is lower than your pre-reset dose
Despite this, the ability of GLP-1 agonists to offer multiple therapeutic effects beyond their primary uses is drawing considerable interest from the medical community
Tissue distribution of the novel DPP-4 inhibitor BI 1356 is dominated by saturable binding to its target in rats
